During the past decade, Hospital General Universitario de Alicante conducted 218 clinical trials. In the 10-year time frame, 218 clinical trials started and 65 clinical trials were completed, i.e. on average, 29.8% percent of trials that started reached the finish line to date. In the past 5 years, 109 clinical trials started and 49 clinical trials were completed. i.e. 45% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General Universitario de Alicante" #1 sponsor was "Pfizer" with 13 trials, followed by "Spanish Breast Cancer Research Group" with 12 trials sponsored, "Boehringer Ingelheim" with 10 trials sponsored, "Gilead Sciences" with 10 trials sponsored and "PETHEMA Foundation" with 10 trials sponsored. Other sponsors include 222 different institutions and companies that sponsored additional 128 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario de Alicante" #1 collaborator was "Pfizer" with 8 trials as a collaborator, "Eli Lilly and Company" with 7 trials as a collaborator, "Hoffmann-La Roche" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator and "AstraZeneca" with 4 trials as a collaborator. Other collaborators include 158 different institutions and companies that were collaborators in the rest 126 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General Universitario de Alicante" are "Atrial Fibrillation" (12 trials), "Atopic Dermatitis" (10 trials), "Breast Cancer" (10 trials), "HIV Infections" (9 trials) and "Carcinoma, Non-Small-Cell Lung" (7 trials). Many other conditions were trialed in "Hospital General Universitario de Alicante" in a lesser frequency.

Most popular intervention types in "Hospital General Universitario de Alicante" are "Drug" (195 trials), "Device" (26 trials), "Other" (25 trials), "Biological" (20 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "Carboplatin" (8 trials), "Cyclophosphamide" (6 trials), "Capecitabine" (5 trials) and "Dexamethasone" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General Universitario de Alicante" are 261 trials for "All" genders, 19 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital General Universitario de Alicante". 3 are not yet recruiting, 68 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 131 completed trials in Hospital General Universitario de Alicante, undefined suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General Universitario de Alicante, 6 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 124 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 22 trials that are defined as “Not Applicable".